The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Doxorubicin conjugated carbon dots as a drug delivery system for human breast cancer therapy
Open accessAbstract
Objectives: Carbon dots (CD s) are one of the most promising carbon‐based materials in bioimaging and drug/gene delivery applications. In this study, we have attempted to study the drug carrying capacity of highly fluorescent CD s for delivery of doxorubicin (DOX) and investigate the therapeutic activity of the CD s‐DOX drug delivery system. Materials and methods: Carbon dots were synthesized by means of a hydrothermal approach with mixing citric acid and ethylenediamine. The properties of CD s were characterized in respects of spectral property, zeta potential, particle morphology and chemical composition. The drug loading efficiency (DLE) and release profile of CD s‐DOX were determined by a fluorescence spectrophotometer. We investigated the cellular toxicity and pharmaceutical activity of CD s and CD s‐DOX in L929 cells and MCF‐7 cells by the CCK‐8 assay. We also studied the cellular uptake of CD s‐DOX with the methods of confocal microscopy and flow cytometry. In addition, the effect of CD s‐DOX on cell apoptosis was assessed by flow cytometry. Results: The obtained CD s possessed good biocompatibility and showed a potential capacity of promoting proliferation. DOX was successfully conjugated to CD s through electrostatic interaction, and the results of the DLE and loading content (DLC) suggested a relatively high drug loading capacity of CD s. Compared with free DOX, the CD s‐DOX complex had a higher cellular uptake and better anti‐tumour efficacy on MCF‐7 cells. Conclusions: The results of this study indicated that the CD s‐DOX drug delivery system had a potential value in cancer chemotherapeutic application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Cited by
Sharma, A., & Das, J. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0525-8 · Cited by 603
Mansuriya, B. D., & Altintas, Z. (2021) · Nanomaterials · doi:10.3390/nano11102525 · Cited by 438
Nanoparticle-mediated targeted drug delivery for breast cancer treatment
Liyanage, P. Y., Hettiarachchi, S. D., Zhou, Y., Ouhtit, A., Seven, E. S., Oztan, C. Y., Celik, E., & Leblanc, R. M. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.006 · Cited by 287
Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
Su, S., & M. Kang, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090837 · Cited by 259
Metadata
- Authors
- Kong, T., Hao, L., Wei, Y., Cai, X., & Zhu, B.
- Venue
- Cell Proliferation
- Publisher
- Wiley
- Published
- 2018-07-24
- Volume
- 51
- Issue
- 5
- Pages
- e12488-e12488
- ISSN
- 0960-7722 (ISSN-L)
- 1365-2184
- OpenAlex
- W2885001542
- Cited by
- 181
- References
- 1
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.